Fpl 14294
Fpl 14294 is a novel CCK-8 agonist with potent intranasal anorectic activity in the rat.
| Supplier | Ace Therapeutics |
|---|---|
| Product # | SMD059 |
| CAS # | 154132-95-3 |
| Pricing | Customizable size, Inquiry |
| Synonym | Fpl 14294; Fpl-14294; Fpl14294; |
| Product Category | Lab-use Small Molecule Drugs |
| Chemical Formula | C45H56N8O13S3 |
| Exact Mass | 1012.3129 |
| Molecular Weight | 1013.16 |
| Elemental Analysis | C, 53.35; H, 5.57; N, 11.06; O, 20.53; S, 9.49 |
| IUPAC/Chemical Name | (5S,11S,14S,17S)-11-((1H-indol-3-yl)methyl)-5-amino-17-((N-methyl-N-(2-(4-(sulfooxy)phenyl)acetyl)-L-phenylalanyl)carbamoyl)-14-(2-(methylthio)ethyl)-6,9,12,15-tetraoxo-2-thia-7,10,13,16-tetraazanonadecan-19-oic acid |
| InChi Key | OHIZQRDUJDNZHS-WZUXKDABSA-N |
| InChi Code | InChI=1S/C45H56N8O13S3/c1-53(39(55)22-28-13-15-30(16-14-28)66-69(63,64)65)37(21-27-9-5-4-6-10-27)45(62)52-44(61)36(24-40(56)57)51-42(59)34(18-20-68-3)50-43(60)35(23-29-25-47-33-12-8-7-11-31(29)33)49-38(54)26-48-41(58)32(46)17-19-67-2/h4-16,25,32,34-37,47H,17-24,26,46H2,1-3H3,(H,48,58)(H,49,54)(H,50,60)(H,51,59)(H,56,57)(H,52,61,62)(H,63,64,65)/t32-,34-,35-,36-,37-/m0/s1 |
| SMILES Code | O=C(NC([C@H](CC(O)=O)NC([C@H](CCSC)NC([C@H](CC1=CNC2=C1C=CC=C2)NC(CNC([C@H](CCSC)N)=O)=O)=O)=O)=O)[C@H](CC3=CC=CC=C3)N(C(CC4=CC=C(OS(=O)(O)=O)C=C4)=O)C |
| Appearance | Solid powder |
| Purity | >98% (or refer to the Certificate of Analysis) |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
| Storage Condition | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | Soluble in DMSO |
| Shelf Life | >3 years if stored properly |
| Drug Formulation | This drug may be formulated in DMSO |
| Stock Solution Storage | 0 - 4℃ for short term (days to weeks), or -20℃ for long term (months). |
| HS Tariff Code | 2934.99.03.00 |